$22.95
7.35% yesterday
Nasdaq, Nov 15, 10:00 pm CET
ISIN
US86881A1007
Symbol
SGRY

Surgery Partners, Inc. Stock price

$22.95
-8.93 28.01% 1M
-4.12 15.22% 6M
-9.04 28.26% YTD
-8.13 26.16% 1Y
-28.09 55.04% 3Y
+11.18 94.99% 5Y
+4.84 26.73% 10Y
Nasdaq, Closing price Fri, Nov 15 2024
-1.82 7.35%
ISIN
US86881A1007
Symbol
SGRY
Sector

Key metrics

Market capitalization $2.92b
Enterprise Value $7.87b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 48.14
EV/Sales (TTM) EV/Sales 2.64
P/S ratio (TTM) P/S ratio 0.98
P/B ratio (TTM) P/B ratio 1.54
Revenue growth (TTM) Revenue growth 9.96%
Revenue (TTM) Revenue $2.99b
EBIT (operating result TTM) EBIT $432.20m
Free Cash Flow (TTM) Free Cash Flow $163.40m
Cash position $221.80m
EPS (TTM) EPS $-0.48
P/E forward negative
P/S forward 1.02
EV/Sales forward 2.63
Short interest 17.52%
Show more

Is Surgery Partners, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,897 stocks worldwide.

Surgery Partners, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Surgery Partners, Inc. forecast:

9x Buy
75%
3x Hold
25%

Analyst Opinions

12 Analysts have issued a Surgery Partners, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Surgery Partners, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
2,985 2,985
10% 10%
100%
- Direct Costs 2,430 2,430
11% 11%
81%
556 556
7% 7%
19%
- Selling and Administrative Expenses - -
- Research and Development Expense - -
-
-
582 582
9% 9%
19%
- Depreciation and Amortization 150 150
5% 5%
5%
EBIT (Operating Income) EBIT 432 432
10% 10%
14%
Net Profit -61 -61
77% 77%
-2%

In millions USD.

Don't miss a Thing! We will send you all news about Surgery Partners, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Surgery Partners, Inc. Stock News

Neutral
Seeking Alpha
3 days ago
Surgery Partners, Inc. (NASDAQ:SGRY ) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Dave Doherty - Chief Financial Officer Wayne DeVeydt - Executive Chairman Eric Evans - Chief Executive Officer Conference Call Participants Jack Slevin - Jefferies Joanna Gajuk - Bank of America A.J. Rice - UBS Andrew Mok - Barclays Tao Qiu - Stifel Sarah James - Cantor Fitzg...
Neutral
GlobeNewsWire
25 days ago
BRENTWOOD, Tenn., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its third quarter 2024 results before the market opens on Tuesday, November 12, 2024, to be followed by a conference call at 8:30 a.m. (Eastern Time).
Neutral
MarketBeat
about 2 months ago
With the stock markets trading near highs again and the start of a lower interest rates cycle, the backdrop for mergers, spin-offs, and acquisitions continues to improve. Elevated stock prices are just as good as currency when trying to acquire another company.
More Surgery Partners, Inc. News

Company Profile

Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services. The Surgical Facility Services segment consists of the operation of ambulatory surgery centers and surgical hospitals, including anesthesia services of the company. The Ancillary Services segment operates a diagnostic laboratory and multi-specialty physician practices. The Optical Services segment involves an optical laboratory and an optical products group purchasing organization. The company was founded in 2004 and is headquartered in Brentwood, TN.

Head office United States
CEO J. Evans
Employees 13,500
Founded 2004
Website www.surgerypartners.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today